Ventyx Biosciences
Joann Tien has extensive experience in regulatory affairs and operations within the biopharmaceutical industry, currently serving as Associate Director at Mirati Therapeutics since June 2021, after holding the position of Sr. Manager in the same department. Prior experience includes roles at ACADIA Pharmaceuticals Inc., where Joann focused on regulatory operations submissions and system management from March 2016 to June 2021, and at Allergan, where Joann held various positions from June 2010 to March 2016, including Senior Regulatory Operations Associate. Joann’s educational background includes a Bachelor of Arts degree in Management/Economics from UC Irvine, obtained in 2010.
This person is not in any teams
Ventyx Biosciences
1 followers
Ventyx Biosciences is a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high-value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Biosciences, targeting NLRP3 and the inflammasome, and Ventyx Biosciences, targeting TYK2.